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Abstract 
Background: Once situated within a care facility or acute hospital, cognitive impairment 
may be overlooked by the clinician. Early identification and intervention is critical not 
only in ameliorating symptoms but also in delaying or potentially arresting further 
cognitive decline. The Mini Mental State Exam (MMSE) has been the cognitive 
assessment tool of choice; however it is no longer freely available. The consistent use of 
a brief screening tool with similar or superior qualities, such as the Montreal Cognitive 
Assessment (MoCA) tool, is needed.  
Aim: To validate the utility of MoCA as a suitable alternative to MMSE in the detection 
of cognitive impairment. 
Methods: The PICO model was deployed to structure the research question and to guide 
the research design. Literature review was deemed to be an appropriate method for the 
purposes of this inquiry; articles retrieved were evaluated for inclusion using the critical 
skills analysis programme (CASP).  
Results: Sensitivity and specificity are pivotal to identifying the validity of a cognitive 
assessment tool, with the use of cut off scores critical to these values. MoCA was more 
sensitive than MMSE in the detection of cognitive impairment and this was particularly 
evident in the case of mild cognitive impairment where persons test as ‘normal’ using 
the MMSE but are identified as cognitively impaired using MoCA.  
Conclusion: Early intervention is key in extending quality of life for persons with 
cognitive impairment. Thus it was determined that MoCA is a valid brief cognitive 
assessment instrument and can be recommended for use by healthcare professionals in 
the early detection of mild cognitive decline.
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Chapter 1: Introduction 
Individuals suffering from the behavioural and psychological symptoms associated with 
cognitive impairment are not always afforded the care they need when their level of 
dependency is not correctly matched to the level of care they require within a residential 
care setting. Cognitive impairment leads to situations where staff are unable to maintain 
an individual’s safety secondary to wandering, poor memory or lack of insight. Staff in 
care facilities also struggle to prevent resident’s dignity from becoming compromised as 
would occur when individuals impaired in regulation of conduct used public spaces to 
perform undressing and hygiene procedures  or toileting. As further examples, they may 
intrude into private spaces, relocate the personal property of others or openly engage in 
verbal and physical assault. In essence these behaviours place individuals at risk of self-
harm or pose a risk to others and they are distressing not only for the individual 
concerned but for all involved in their care. 
Older adults are a vulnerable population and at the time they enter into residential care 
they are likely to have at least one chronic condition which is often accompanied by 
multiple comorbidities and may include cognitive impairment (Boyd et al., 2008). 
Cognitive impairment is a subtle insidious condition which affects a significant number 
of individuals as they age and currently there is no process in place to routinely screen 
for impairment prior to an individual’s admission to a care facility. There is also no 
consistency in utilisation of a cognitive screening instrument and this potentially 
impedes the transfer of generalizable information between clinicians. It seems 
appropriate that routine cognitive screening practices be put into place and, ideally, a 
validated cognitive assessment tool be used to enable the transfer of generalizable 
information. The purpose of this dissertation is to explore two commonly used cognitive 
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assessment tools to identify their suitability for use by nurses in residential care 
facilities. 
Cognitive impairment; the situation in New Zealand 
In  response to a call from the World Health Organisation [WHO] to give public health 
priority to dementia (WHO, 2012) each New Zealand District Health Board [DHB] was 
given additional annual funding ring-fenced with the mandate to develop clear pathways 
for people with dementia in order to maximise wellbeing and ensure they are supported 
to be as independent as possible. Collaboration between the Ministry of Health [MOH] 
and DHB’s has resulted in New Zealand’s Framework for Dementia Care (MOH, 
2013). The aim of the framework is to ensure clear guidelines for dementia pathway 
development ensuring that the individual with dementia has access to services as early 
as possible and that these continue to end of life. The Framework advocates early 
identification of cognitive decline as a priority and any individual with known risk 
factors should be offered routine monitoring including an assessment if cognitive 
impairment is suspected. Another framework requirement is that health services 
“develop a standardised assessment process that is culturally sensitive, comprehensive 
and follows the National Institute for Health and Clinical Excellence [NICE] clinical 
guideline 42, using a validated assessment tool” (National Institute for Health and 
Clinical Excellence, 2006, p. 16). The NICE clinical guideline 42 (2006) names MMSE 
(see Appendix B) as a standardised instrument for use in formal cognitive assessment. 
In contrast, the New Zealand Framework for Dementia Care (2013) identifies MoCA 
(see Appendix C) as a validated tool for clinical cognitive assessment, stating that it 
meets good practice criteria.  
In aged care facilities nurses are able to play a key role in improving the situation for 
individuals with deteriorating cognition through use of a brief cognitive screening tool. 
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The results of a cognitive assessment could be used to support an application for clinical 
review potentially culminating in improved case management through the application of 
relevant interventions. The choice of tools to explore was a result of my working within 
a single DHB in Auckland. The residential care facility where I was working when this 
project began utilised the MMSE to assess cognition and the DHB within which the 
residential care facility is located utilised MoCA. Because of the ongoing discourse 
regarding which cognitive assessment tool was superior, MMSE or MoCA, the PICO 
model was engaged and applied to the identified problem in order to arrive at a research 
question and an appropriate research design to enable resolution. This process will be 
described in detail but in brief, the research problem identified was a need for nursing to 
be able to utilise a valid brief cognitive instrument in order to detect clinical cognitive 
deterioration and direct appropriate care. The research question arrived at was “Is the 
Montreal Cognitive Assessment a suitable replacement for Mini Mental Status 
Examination in the detection of clinical cognitive deterioration?” At this point a 
literature review using the critical skills appraisal programme was deemed a valid 
methodology. 
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Chapter 2: Background 
The purpose of this project is to establish whether MoCA is a suitable tool to replace 
MMSE in the detection of cognitive impairment. A reliable and validated brief 
cognitive screening tool is necessary for use in the early identification of cognitive 
decline in older aged individuals living within New Zealand’s’ residential aged care 
setting. 
Population of Interest 
One criterion for government funded admission into New Zealand residential aged care 
is that individuals are aged 65 years and over, therefore cognitively impaired individuals 
within this age group are of interest for this project. Within the residential care setting 
there will be individuals who were cognitively intact on admission and who exhibit 
symptoms suggestive of cognitive impairment. Early recognition is important as the 
individual can then be facilitated to live well and meet challenges in order that well-
being is maximised (MOH, 2013). The governmental drive for early intervention is 
promoted by many factors including recognition that 50% of persons with mild 
cognitive impairment will convert to dementia (NICE, 2006). 
Early diagnosis of cognitive impairment also facilitates the identification of underlying 
medical conditions. Sometimes treating underlying conditions can result in reversal of 
symptoms and/or delay the progression of the condition to dementia. For example 
vascular causes of cognitive decline can be treated to prevent further deterioration. 
Alternatively, dementia specific medications such as Donepezil can be administered, 
which when given early enough can delay dementia, affording the person with dementia 
and their family time to put in place any legal or financial planning as well as 
establishing advanced care directives (Chen, Leung, & Chen, 2011). Psychosocial, 
occupational and physical interventions can be facilitated in a timely manner; not only 
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does this serve to assist individuals and their families, but can also result in a delay of 
cognitive decline and prevention of other adverse events (WHO, 2012). In order that the 
population within the studies reviewed are aligned with those for whom the problem 
statement was initiated it is desirable to review studies of older aged cognitively 
impaired individuals who are situated within a residential care setting. Should studies 
not include all elements of the population of interest then quality analysis of the studies 
highlighting the relevance of explicit findings in relation to the local population will be 
important. For example, it is feasible that the care setting from which a population is 
sampled may prove irrelevant to the findings. 
Interventions of Interest 
One intervention enabling early identification of cognitive difficulty and which forms 
the backbone of this project is cognitive assessment screening. This literature review 
will seek to understand the similarities and differences between the two selected 
cognitive instruments, MMSE and MoCA. The aim is to establish whether one 
instrument demonstrates better diagnostic utility in the detection of cognitive 
impairment. It is therefore important to confirm those traits desirable in a suitable 
cognitive screening instrument in order to provide reference points for the critique. 
According to Larner (2013) the ideal cognitive assessment instrument would be capable 
of being administered in 15 minutes or less by any clinician. It should test cognition in 
the domains of visuo-spatial skill and executive function, memory, language, attention 
and orientation. It should require use of minimal resource, be reliable, and possess test-
retest and inter-rater validity as well as being able to detect cognitive disorder. Tests 
should be easy to interpret and should include clear cut off scores (Larner, 2013).  
I begin the literature review in examining what Folstein, Folstein and McHugh (1975) 
write about the cognitive screener that they developed, MMSE and in what Nasreddine 
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et al (2005) write about their cognitive screening instrument, MoCA. Review of each 
tool will facilitate the comparison of one tool with the other as well as providing context 
when comparing what is known about each tool in relation to information uncovered 
secondary to the literature review. 
Mini Mental State Examination (MMSE) 
MMSE was designed to provide a simple, scored and brief tool with which to screen 
cognitive status while also capable of being administered within 5 to 10 minutes 
(Folstein et al., 1975). The developers did not intend that MMSE replace a complete 
clinical appraisal nor be a stand-alone tool upon which a diagnosis could be made. An 
“accurate diagnosis including appraisal of the significance of cognitive disabilities 
uncovered in MMSE depend on the evidence provided by a full psychiatric history and 
pertinent laboratory data” (p. 195). 
The developers claimed that MMSE provided a reliable and valid quantitative measure 
of cognitive function for use in discriminating between those individuals with cognitive 
disturbances from those with none. A main finding in scoring was that the mean score 
for “normal” was 27.6; this score agreed with the “clinical opinion of the presence of 
cognitive difficulties” (Folstein et al., 1975, p. 192). MMSE was said to be ideal for 
initial and serial measurements and could demonstrate a decline or improvement in 
cognitive status over time and with treatment. Folstein et al (p. 195) found MMSE 
“makes more objective what is commonly a vague and subjective impression of 
cognitive disability during the assessment of a patient. MMSE has become one of the 
most commonly used brief measures of cognitive status worldwide. 
Licensing of MMSE 
During the course of this literature review it was uncovered that there exist copyright 
issues with MMSE and this is perhaps the reason why the DHB no longer uses this tool. 
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Unless the test is able to be administered from memory, a license must be purchased 
from www.parinc.com. There may be some protection afforded under the “fair use law” 
in certain non-profit situations such as research, but this only applies to limited and 
unspecified parts of the tool (Newman & Feldman, 2011). It seems that information 
relating to copyright is as yet, largely unknown; copyright is not consistently reported in 
even the most recently published research. Certainly within the residential care facility 
where I worked, MMSE was administered without knowledge that copyright was being 
breached. Copyright issues alone will suffice to ensure many seek to utilise an alternate, 
suitable and valid brief cognitive screening tool.  
The Montreal Cognitive Assessment (MoCA) 
Nasreddine et al (2005) developed the MoCA which aimed to support physicians in the 
detection of mild cognitive impairment (MCI) and which was capable of being 
administered within ten minutes. Originally designed to test across ten cognitive 
domains which were generally found to be defective in persons with MCI, the current 
MoCA tests performance in eight cognitive domains. At the time of its development, no 
other screening tools were able to reliably and quickly distinguish MCI in individuals 
from a population of normal controls. Nasreddine et al recommend a cut off score of 26 
where those who score 26 or more would be “extremely unlikely to meet clinical and 
neuropsychological criteria for MCI even after extensive evaluation” (p. 698). 
Education was noted to correlate with poorer MoCA performance in those persons with 
≤12 years of education and to correct for this potentially confounding factor, it was 
recommended 1 point is added to a person’s total score if that score is <30 and the 
individual had ≤12 years of education. 
Nasreddine et al claim MoCA is a “simple stand-alone cognitive screening tool with 
superior sensitivity” (2005, p. 698). The reasons for the superior sensitivity using 
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MoCA are inherent in the design; memory testing in MoCA involves “more words, 
fewer learning trials and a longer delay before recall” (p. 698). Unlike MMSE, MoCA 
incorporates more numerous and demanding tasks assessing executive function, higher 
level language ability and complex visuospatial processing, which can be impaired in 
persons with MCI. 
Neuropsychological Battery 
Comprehensive neuropsychological battery (NP battery) is suggested to be the gold 
standard in cognitive testing; however, a paucity of specific information became 
apparent. I have concluded that an NP battery can consist of a number of individual 
tests selected to specifically assess performance in various cognitive domains and this 
will be discussed further when evaluating the literature review findings. 
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Chapter 3: Research design 
In meeting criteria assessing an individual’s dependence or in being deemed to have an 
irreversible condition, older aged people admitted into residential aged care can be said 
to constitute a vulnerable population. When they become cognitively impaired or their 
existing impairment deteriorates they clearly become a group in need of strong 
advocacy in order to assist them to obtain access to relevant services. As nurses we are 
well placed to note changes in an individual’s cognitive status, but do not always have 
access to a designated tool by which the relevant and vital information pertaining to the 
deterioration is easily collated for communication to other health professionals. As 
described in the introduction, the purpose of this research project is to identify a brief 
cognitive assessment tool capable of validating clinical deterioration in cognitive 
impairment. In reviewing available literature a plethora of available cognitive 
measurement instruments became evident; however, the most commonly used tools 
within clinical practice locally are the MMSE and MoCA. 
Step One: Identifying a focus-based question 
The first stage in evidence based healthcare is the ‘translation of uncertainty to an 
answerable question’ (Pearson, Wiechula, Court, & Lockwood, 2005, p. 208). A 
research question is defined as an ‘explicit query about a problem or issue that can be 
challenged, examined and analysed and that will yield useful new information’ (Wood 
& Ross-Kerr, 2010) . The specific clinical issue at hand was that nurses need to be able 
to utilise a valid cognitive assessment tool in order to detect cognitive impairment in a 
residential care population of older aged individuals. The first step was to formulate a 
focussed clinical question based on the specific clinical issue. Questions are the “driving 
force behind evidence based practice and the most challenging aspect is to identify an 
answerable question” (Davies, 2011, p. 75). A decision was made to structure the 
research question using the PICO model. 
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Developed by Richardson, Wilson, Nishikawa and Hayward (1995), the PICO model 
provides a framework within which a research question can be structured. The elements 
of PICO are patient population (P), an intervention or independent variable (I), 
comparison (C), the dependent variables or outcome of interest (O). This paper focusses 
on older individuals identified as those aged 65 years of age and over (P). The 
intervention being studied comprises cognitive assessment (I) and specifically 
comparing an individual’s performance using MMSE and MoCA (C). The outcome is to 
distinguish whether the MoCA is a suitable replacement tool for MMSE in detecting 
cognitive impairment. Therefore the focus based question for this evidence based 
literature review is, “Is the Montreal Cognitive Assessment a suitable replacement for 
Mini Mental Status Examination in the detection of clinical cognitive deterioration?” 
Step Two: Conducting a literature search 
Trainor & Graue (2014) write that “theory gleaned from extant literature informs the 
research question and purpose as well as the design and analysis” (page 114). Literature 
review is the second stage of evidence based healthcare and involves the “systematic 
retrieval of the best evidence available” (Pearson et al., 2005, p. 208). To locate 
literature which would assist in answering the identified PICO, specific databases, 
search terms and limits were used. These are summarised in Table 1. An English 
language literature search was undertaken and databases searched included Wiley online 
library, Medline via PubMed, Academic search premier via Ebsco Host, Academic 
research library via ProQuest, the Cochrane library via Ovid, Evidence based medicine 
via Ovid and Summon online portal via AUT library. Primary search terms used were 
‘MMSE’ and ‘MoCA’, secondary search terms used were “superior” and “comparison.” 
Limits used included those articles which were published within scholarly or peer 
reviewed journals and available in full English text. 
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Study selection 
Articles identified from the electronic searches were then manually reviewed to identify 
those that were not applicable and identify duplicates. Inclusion criteria included articles 
with a main focus on comparison between MMSE and MoCA. Potential articles were 
selected by title and abstract, and where deemed relevant the full article was retrieved. 
An in depth article review was then conducted to evaluate content in relation to the 
validity of each cognitive assessment tool in relation to the other. Research articles were 
manually searched including reference lists for further relevant articles not located 
through databases, a practice endorsed by the New Zealand Guidelines Group (2001). 
Exclusion criteria included articles with a main focus on a different condition, the use of 
a cognitive assessment tool other than MMSE or MoCA, not constituting a comparison 
study, not focussing on the detection of cognitive impairment, written in another 
language (despite limiting the search to English) and not available for retrieval (no full 
text availability or too new to be available for downloading). 
In total 508 articles were identified in the early searching phase and of these 495 articles 
were excluded based on overwhelming broadness to the research topic or where the data 
was unlikely to be extrapolated into the residential care setting, see table 1 . A total of 
13 documents were included for review and the researcher moved to the third step in the 
process.
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Table 1: Literature Search  
This table shows the gross numbers of articles retrieved through searching using the key words and in applying the limiters described. The total remaining following exclusion criterion 
application are shown and the overall total of articles selected for inclusion in the literature review is 13. Key to search terms: (a) MMSE (b) MoCA (c) superior (d) comparison 
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Step Three: Critical appraisal 
The third stage in evidence based healthcare is critical appraisal of the evidence for 
validity (Pearson et al., 2005) and this occurs through evaluating the rigour of the 
study design and methods, in identifying the findings and considering the relevance of 
the findings to the research question. 
Quality assessment (CASP) 
The Critical Appraisal Skills Programme tool provides the framework for critique in 
this literature review.  Developed during 1993 in Oxford by Dr Amanda Burls, CASP 
provides a basis to ensure appraised research is reliable, relevant and unbiased (Singh, 
2013). There are different tools for each of the study designs: randomised controlled 
trials (RCT’s), systematic reviews, qualitative, case control, diagnostic, cohort, 
economic evaluation and clinical prediction rule (CASP, 2013).  
CASP enables a sound approach to evidence based assessment with the primary goal 
being to establish validity within a study for review. Each CASP tool is comprised of 
three sections which in combination establish study validity; the first section is internal 
validity or rigour of the tool, the second section evaluates the results of the study and 
the third requires consideration of the results and their application to practice.  
Each section of a CASP tool provides prompts which facilitate the researcher in 
ensuring all important factors are considered when evaluating studies. CASP provides 
the analysis framework and can be seen in Appendix A. Use of CASP facilitates the 
independent evaluation of each article allowing themes to become apparent. Identified 
themes can then be explored in relation to whether MoCA is a valid cognitive 
assessment tool for the detection of cognitive impairment such that it can be used in 
place of the MMSE. CASP analysis of the literature reviewed is presented in table 2. 
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Table 2: CASP analysis 
This table shows the CASP analysis for each of the articles reviewed.  
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Chapter 4: Data 
Using the critical appraisal skills programme and the PICO model thirteen articles 
were critiqued to determine the validity and reliability of MMSE compared to the 
MoCA. The thirteen articles evaluated were comprised of eleven cross sectional and 
two case control studies. 
Study designs  
 
The studies consisted of eleven cohort studies and two case control studies. Cohort 
and case control studies are both examples of observational study designs used in 
quantitative research; the “researcher collects information on the characteristics, 
attributes or measurements of interest” (Healy & Devane, 2011, p. 32). Observational 
study designs are used to describe or compare and this project has reviewed 
comparative studies in which there is an attempt to quantify the relationship between 
two factors. The main focus of this project was to assess and quantify the relationship 
between the capacity of MMSE compared to the capacity of MoCA in the detection of 
cognitive impairment.  
Cohort studies can be cross sectional in design meaning that the measurement of 
interest occurs at one point in time; there were three cross sectional studies. Cohort 
studies can also be longitudinal in design meaning that data is collected at several 
points in time; seven of the studies were longitudinal. Cohort studies can also be 
described as retrospective meaning that the study looks back in time to collect data 
about the measurement of interest (Healy & Devane, 2011); one study was conducted 
retrospectively. The findings of cohort studies provide information about associations 
between variables; the “strength and consistency of associations can be used to draw 
inferences about causation” (Healy & Devane, 2011, p. 36). 
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The strengths or advantages in cohort study design are that they can document 
progression of disease and measure incidence rates while allowing the study of 
multiple potential effects (Healy & Devane, 2011). Cohort studies also permit 
flexibility in the selection of variables to be evaluated and provide detail on risk 
factors. The weaknesses or disadvantages in cohort study design are that they can be 
expensive to conduct and have a potentially long duration for follow up which means 
that they can yield a high dropout rate. Healy and Devane (2011) maintain that cohort 
studies require a large sample size and this especially challenging in the case of rare 
disease. Also, it can be difficult to control for extraneous variables in cohort studies 
and it is possible exposure may be linked to unknown confounding factors. Healy and 
Devane (2011) find that blinding is not always achievable and exposure or practices 
can change over the study timeframe rendering the results irrelevant.  
Case control studies examine individuals with a particular condition (cases) and 
compare them to individuals who do not have the condition (controls). Data is 
collected about the two groups of people and comparisons made to determine whether 
there are any characteristics which are contributing to the finding (Hoe & Hoare, 
2012). In the two case control studies reviewed, data is collected about the capacity for 
MMSE and MoCA to detect cognitive impairment in individuals post stroke and in 
individuals known to have Alzheimer disease (AD) and compared to data collected 
about the capacity for MMSE and MoCA to detect cognitive impairment in healthy 
individuals. Historically case control studies have been thought inherently prone to 
bias and therefore considered less valid than cohort studies. However, a London based 
professor of epidemiology and biostatistics writes this is fallacious (Pearce, 1993). 
Case control studies are said to be “indispensable if the disease is rare or assessment of 
the exposure is expensive, and in situations where results are needed quickly” (Knol, 
Vandenbroucke, Scott, & Egger, 2008, p. 1073). 
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To improve rigour in study design, eligibility criteria should be standardised and any 
“diagnosis should be made by healthcare professionals with expertise in differential 
diagnosis using international standardised criteria” (NICE, 2006, p.21). International 
standardised criteria include DSM-IV, Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition; ICD-10, International Classification of Diseases, 10
th
 
revision; NINCDS/ADRDA, National Institute of Neurological and Communicative 
Diseases and Stroke/Alzheimer’s Disease and Related Disorders Association; NINDS-
AIREN, Neuroepidemiology Branch of the National Institute of Neurological 
Disorders and Stroke Association Internationale pour la Recherche et l’Enseignement 
en Neurosciences (NICE, 2006). Within the articles reviewed for this project only one 
study utilised criterion from the above; Tu et al (2013) used NINDS-AIREN. 
Interesting to note is that NINCDS/ADRDA can only be utilised post mortem at 
autopsy and this makes its deployment somewhat less feasible than the others. Also of 
interest was an incidental finding that ICD-10 is utilised for clinical coding purposes 
within MOH New Zealand and it would be logical to assume that ICD-10 is preferred 
in the classification of diseases and related health problems within this country’s 
health systems.  
Study participants 
The intent of this project as guided by PICO was to evaluate findings for relevance to 
individuals aged 65 years or over; 65 years of age is aligned with the criterion 
requirement relating to government funding of individuals into NZ aged residential 
care. The critique has identified age as a potential confounding factor for which 
adjustments have been deployed in the majority of articles; the older age groups have 
been shown to score less well in both MMSE and MoCA.  It was identified that 
explicit criteria outlined for population for this project were not met. Most studies 
documented the mean age for their subjects and this ranged from 65.0 years within the 
Zadikoff et al research (2008) to 72.7 years within the control group of the Dong et al 
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research (2012). Where non-statistical information was provided the range of ages was 
as young as 47 to as old as 100. As a result of inclusion criteria within some studies, 
the age of individual participants may have been outside of the population of interest 
for this project. As an example, Toglia et al (2011) used inclusion criteria for their 
study which allowed inclusion of individuals >18 years of age. I assume that the 
inclusion criteria in relation to age as used by Toglia et al was opportunistic in that it 
likely reflects admission criteria to the stroke inpatient bed within the facilities where 
sampling for the study occurred. However, as the focus of this project is cognitive 
impairment and vascular cognitive impairment is strongly associated with stroke, an 
incidental younger aged individual may not have confounded results. Additionally, 
although cognitive impairment mainly affects older individuals, it is thought the onset 
of up to 10% of all cases occurs before 65 years of age (WHO, 2012). 
 There was no consistency in the presentation of data relating to gender; some studies 
reported gender as a percentage of the total number of individuals studied while others 
provided pure numerical detail. However, overall the data revealed a higher incidence 
of male subjects which is not reflective of the local population; prevalence for 
dementia in NZ individuals aged 74 years and over is predominantly female 
(Alzheimers, 2008). There was a paucity of information indicating the relevance of 
gender to the data findings or discussion.  
Data for education is mostly given as a mean number of years and this data ranges 
from as little as ≤2 years (Tu et al, 2013) to 16.4 years. Education has also been found 
to be a potentially confounding factor; individuals with low level of education have 
been found to score less well than those with higher number of year’s education and a 
scoring adjustment is made in many studies. In New Zealand the proportion of adults 
with secondary school qualifications has shown an increase of 14% since 1991; 76.2% 
are found to have a secondary school level of education in the most recent census 
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(Statistics New Zealand, 2013). However, this may not reflect the educational level in 
the local population as a higher level of education was not as necessary historically, 
certainly among our oldest old population, to allow them entry to paid employment as 
it is in contemporary society. 
In line with PICO, the intervention of interest is the MMSE and the MoCA cognitive 
assessment tools and in particular a focus on comparing the reliability and validity of 
each respective cognitive assessment tool in relation to the detection of cognitive 
impairment. All participants were administered both MMSE and MoCA in all the 
studies reviewed; therefore all articles provide findings in relation to each cognitive 
assessment tool’s ability to detect cognitive impairment and this should facilitate 
comparison. Additional comparison is offered in six of the studies through the use of 
the ‘gold standard’ approach where performance is also rated in comparison to the 
findings of a comprehensive neuropsychological battery (Cumming, Churilov, Linden 
& Bernhardt, 2012; Damian et al, 2011; Godefroy et al, 2011; Hoops et al, 2009; Roalf 
et al, 2013; Tu et al, 2013). Outcome is represented statistically in most studies and 
varying statistical procedures have been applied to the data. Differences in study 
design and statistics deployed result in some difficulties with regard to interpreting the 
data and this is enlarged upon within the discussion chapter.  
Thirteen studies were subject to CASP analysis. The CASP tables provide a snapshot 
of each study itemising the research problem and the purpose of the study. Brief 
information is provided around each author’s consideration for bias and how this was 
mitigated. Study results are presented and confirmation made as to whether the results 
have been found credible and whether they are in alignment with all studies reviewed. 
Finally a consideration is made as to whether the results would benefit the local 
population, see Table 2. 
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Table 3, represents salient findings of the review which are extrapolated for address 
within the discussion; clustering of the data within a table facilitates comparison 
across all the studies. This figure provides a snapshot regarding demographic detail of 
study participants and lists statistical methods deployed in meta-analyses where 
relevant. Where comprehensive neuropsychological testing has occurred within a 
study, a list is provided regarding the items deployed when these have been identified. 
Finally where diagnostic criteria have been operationalised, the criteria are listed. This 
data has been graphically presented as it has bearing as to whether or not the findings 
of the study are validated and this is discussed within the following chapter. 
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Table 3: Study Comparison     
This table allows identification of varying statistical procedures used to quantify cognitive impairment as well as demographic data of participants, whether standard criterion were used 
to operationalise diagnoses and which if any domain subtests were deployed. 
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Summary of CASP analysis findings: Identification of themes 
In alignment with the statement by Higgins and Green (2011) the focus of this project is 
“examining the relationship between some clinical characteristics of the studies 
reviewed and the size of the intervention effect rather than on obtaining a summary 
effect estimate across a series of studies” (page 301). Accordingly within this literature 
review themes such as sensitivity, specificity and cut off scores became evident and it 
was thought relevant they be explored as foundational components of the review. 
Initially individuals with dementia were thought to be the population of interest 
however there is a shift in current literature from dementia to cognitive impairment to 
the extent that an announcement is made that the term dementia is to be “replaced by 
major or minor neurocognitive disorder in the updated DSM-V due to be published late 
in 2013” (Sorbi et al., 2012, p. 1161).    
Advances are progressing rapidly in the diagnosis and management of cognitive 
impairment and although many individuals with mild cognitive impairment will 
progress to dementia, with early intervention there is increased capacity to delay onset, 
ameliorate symptoms and in some cases, prevent deterioration. While earlier studies 
were focussed predominantly in the arena of Alzheimer’s disease and other dementia 
subtypes, emerging studies have shifted focus to the validity of screening instruments in 
relation to identifying cognitive impairment in those at risk such as individuals with 
Parkinson’s disease, cardiovascular disease and stroke. All are represented within the 
articles reviewed. The evolving focus is enabling critical relationships to be drawn 
between the cognitive domain of impairment and the underlying condition; this is 
underpinning greater understanding in regard to the reasons individuals with certain 
conditions display particular behaviours.  
Larner (2013, p.225) writes that “cognitive impairment may occur in many neurological 
diseases.” He points out that some cognitive assessment tools are designed to test for 
impairment in individuals with specific conditions, such as Multiple Sclerosis wherein 
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cognitive impairment is common. It appears that testing is now occurring to determine 
whether any particular instruments are more capable in detecting cognitive impairment 
when specific diagnoses are suspected, such as vascular dementia secondary to stroke 
(Larner, 2013). I believe this is visible in the studies reviewed where the populations 
include individual’s with Parkinson disease, transient ischaemic attack and stroke. 
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Chapter 5: Discussion 
The purpose of this literature review was to identify whether MoCA was a suitable 
alternative to use in the place of MMSE for the detection of cognitive impairment. The 
findings using CASP analysis uncovered several aspects which are significant to the 
interpretation of these two screening tests and will be discussed in this section.  
Cognitive Domains 
The cognitive domains which are thought significant to decisions around general 
cognition and which are tested in MMSE and/or MoCA include the 
visuospatial/executive, naming, attention, language, abstraction, delayed recall and 
orientation; unlike MMSE, MoCA tests all of these domains. MMSE does not test 
executive function or abstraction and there is considerable support in articles reviewed 
which suggests that visuospatial testing is virtually non-existent in MMSE as well.  
Visuospatial/Executive Domain 
The visuospatial and executive function domain is tested using three tasks; modified 
trail making, copying of the cube, and clock drawing in MoCA. Neither trail making nor 
clock drawing are used in MMSE. Instead, MMSE assesses visuo-motor function 
through copying of two intersected pentagons. Indeed, the studies indicate that the 
insensitivity of MMSE to MCI is strongly associated with the lack of testing in the 
domain of visuospatial and executive functioning. This ensures that MoCA is found 
superior to MMSE in its ability to detect cognitive impairment. Cameron et al (2013) 
found that 81% of the patients they studied demonstrated task errors in the executive 
function domain of MoCA which, as they highlighted, is not assessed in MMSE. This 
was supported in the findings of another study where it was suggested that lower scores 
obtained when measuring using MoCA are largely attributable to errors in 
visuospatial/executive and fluency items, not represented in MMSE (Toglia et al, 2011). 
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Naming Domain 
In MoCA, the naming domain is tested using a “three item confrontation naming task 
with low familiarity animals” (Nasreddine et al., 2005, p. 697) a camel, lion and 
rhinoceros. Similarly, in MMSE this domain is tested through showing the subject a 
pencil and then a wristwatch and asking what they are called. Both MMSE and MoCA 
have been criticised for ceiling effect in this cognitive domain; the tasks are too easy 
(Damian et al., 2011; Pendlebury et al., 2012). However, Julayanont, Phillips, Chertkow 
and Nasreddine (2013) state that confounding factors may include those individuals 
with low education level or cultural unfamiliarity with the animals and this may explain 
low scoring in some populations. Another low scoring population are those individuals 
with Parkinson disease where pathology includes disrupted subcortico-frontal pathways. 
It is interesting to note that the naming of animals (MoCA) was more highly associated 
with primary visual cortex activation than the naming of tools (MMSE) which is 
associated with frontal and parietal lobe activation (Julayanont et al, 2013, p. 116). 
Attention Domain 
The attention cognitive domain is tested using three tasks; the digit span, the letter A 
tapping test and serial 7 subtractions using MoCA. Neither digit span nor the letter ‘A’ 
tapping test are used in MMSE. Instead MMSE assesses attention using only serial 7 
subtractions. It seems logical therefore, that the lack of testing in this cognitive domain 
using MMSE results in the finding that MoCA has superiority over MMSE. For 
example, prominent attentional deficits are expected in individuals with a vascular 
pattern of cognitive impairment (Pendlebury et al., 2012, p. 49). Deficits in attention 
were also commonly found in individuals with right hemisphere lesions (Cumming et 
al, 2012). Previously it has proved difficult to determine inattention in right hemispheric 
stroke patients when using MMSE; this finding was thought to be clinically significant 
as it indicates a possibility that MoCA may help identify those patients with agnosia and 
inattention (Cumming et al, 2012).  
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Language Domain 
The language domain is tested using five tasks; naming, sentence repetition, letter 
fluency, three stage command and copying a design using MMSE. Naming, three stage 
command and copying a design are used and scored, within the naming domain and the 
visuospatial/executive function domain using MoCA. Sentence repetition is also used in 
MoCA and additionally MoCA uses the letter ‘F’ fluency task. It is interesting to note 
that semantic fluency is substituted for letter fluency where the latter does not exist, as 
occurs in languages such as Korean and Chinese (Julayanont, Phillips, Chertkow, & 
Nasreddine, 2013, p. 118). In my opinion, where substitution of letter fluency for 
semantic fluency occurs, a confounding factor is introduced. In evaluating cognitive 
performance in this domain, the studies identified pro’s and con’s for both MMSE and 
MoCA as follows. MMSE was found to have a “propensity for relatively easy verbal 
item tasks that do not have the sensitivity to identify subtle language deficits” 
(Cameron, Worrall-Carter, Page, Stewart, & Ski, 2013, p. 257). Pendlebury et al (2010) 
also found the sentence repetition task using MMSE did not find task errors as 
frequently as the sentence repetition task using MoCA. It was suggested by Toglia et al 
(2011) that lower scores obtained when using MoCA are largely attributable to errors in 
visuospatial/executive function and fluency items; neither are represented in MMSE. 
Conversely, a secondary analysis performed to compare the agreement between MMSE 
and MoCA with the neuropsychological battery found MMSE had a “particularly 
pronounced agreement with the neuropsychological battery” in the language domain 
(Cumming et al, 2012, p.127). I suggest that an important consideration with regard to 
the secondary analysis is the tasks the authors incorporated into their 
neuropsychological battery to assess cognition in this domain; there is potential for the 
introduction of a confounding factor here. 
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Abstraction Domain 
Abstraction is tested using one task twice; the subject is asked to state what similarity 
exists between two items presented to them using MoCA (the Wechsler similarities 
test). MMSE does not test cognitive function in this domain. Individuals with 
Alzheimer’s disease (AD) and Huntington’s disease perform poorly in this test and 
individuals with fronto-temporal dementia exhibit more task errors than individuals with 
AD (Julayanont et al., 2013). Performance decline in this test is a predictor for 
conversion of individuals to AD (Julayanont et al., 2013). One study reported that the 
individuals studied scored lowest in abstraction domain (Pendlebury et al., 2012).  
Delayed Recall Domain 
The delayed recall domain is tested using one task in both MMSE and MoCA. 
However, MoCA requires the subject to recall five words which are given to the subject 
and repeated once only at the time of registration and this task is not scored; the subject 
is asked to recall the five words after a 5 minute interval and the delayed recall task is 
scored. In contrast using MMSE, the subject is given three words at registration and the 
words are repeated until the subject is able to verify the ability to recall them and 
registration is scored; they are asked to repeat the words back to the assessor following 
a five minute interval and delayed recall is scored. In evaluating task performance using 
MMSE and MoCA subjects were found to score poorly in delayed recall.  
Delayed recall of five items using MoCA was said to have a flooring effect; it was too 
hard and therefore a poor discriminator in more cognitively impaired individuals 
(Pendlebury et al., 2012). The study by Cameron et al (2013) found that 96% of patients 
scored poorly for this domain using MoCA in comparison to 75% who scored poorly in 
the same domain using MMSE. Additionally, MoCA provided an option to perform 
cued memory recall once the delayed recall task was completed and scored. It was 
suggested this may result in collecting more information regarding group differences 
(Pendlebury et al., 2012).  
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Julayanont (2013) raised an important consideration in identifying that individuals with 
AD are prone to perform poorly in the recall domain owing to semantic memory 
impairment; this can be further confounded through low education level and/or literacy 
ability. But of further concern was the statement that memory recall, language and 
executive functions were most frequently impaired tasks in those identified as 
cognitively impaired using MoCA; these domains are those needed for learning and the 
“development of self-care management skills” (Cameron et al., 2012, p. 258). 
Orientation Domain 
Tasks performed in the orientation domain are the same in both MMSE and MoCA to 
the extent that Cumming et al (2012) note that as “MoCA overlapped with identical 
items on MMSE” the items were tested only once (p. 123). An important finding for 
nurses working within the residential aged care setting is that performance in the 
domain of orientation is promoted as the “single best predictor of daily functions in 
individuals with dementia” (Julayanont et al., 2013, p. 119). Another finding worth 
noting was the only significant difference in task performance between a TIA 
population and a stroke population occurred in the cognitive domain of orientation and 
specifically temporal orientation (Pendlebury et al., 2012). Indeed temporal orientation 
has been found sensitive in the detection of individuals with dementia and in those with 
delirium and additionally, temporal orientation status can “predict overall cognitive 
decline over time” (Julayanont et al, 2013; p. 120). 
Neuropsychological battery 
The gold standard in cognitive testing is the comprehensive ‘neuropsychological 
battery’ (NP battery). The neuropsychological battery consists of a number of individual 
tests selected to specifically assess performance in various domains. There is, however, 
no one neuropsychological battery which is consistently used. Dong et al (2012) 
highlight that different “formal neuropsychological battery are used to define cognitive 
status” (p.1753), and that this accounts for differences in research findings across 
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studies. They go on to say that other studies used either “short NP batteries or isolated 
memory functioning subtests while we employed a more comprehensive NP evaluation 
which covers a wide range of cognitive domains.” In addition, Roalf et al (2013) was 
concerned that neuropsychological (NP) testing was neither a time nor a cost efficient 
way in which to reliably differentiate MCI from dementia and advocated the use of brief 
cognitive screening tools under the proviso that established cut off scores and 
confidence intervals be validated.  
This literature review has revealed there was no consistency in the use of NP battery, 
neither in the selection of individual cognitive domains for testing, nor in which of the 
available subtests were applied. As an example Hoops et al (2009) opportunistically 
extracted cube copying from the MoCA and utilised it to inform the evaluation of 
visuospatial domain within the comprehensive neuropsychological battery. This 
introduces potential bias to the NP battery used.  Roalf et al (2013) utilised an NP 
battery known as the CERAD-NP which dictates and lists the subtests to be utilised 
thereby providing a platform which facilitates consistency and allows results to be 
generalized. However the CERAD-NP incorporates MMSE. Accordingly, would use of 
this particular NP therefore place users in potential breach of the copyright issues 
associated with MMSE? Moreover as MMSE has been found to lack sensitivity to MCI, 
CERAD-NP is likely to be equally unreliable in the detection of MCI. The aim of using 
a neuropsychological battery is to determine the discriminant validity of MMSE and 
MoCA, thus the use of CERAD-NP as the gold standard introduces bias.  
There appears to be a plethora of available tests and some used in the studies reviewed 
within this project date back to 1958 (Stroop test). In light of the fact that deployment of 
a gold standard is so variable and that that NP battery are predominantly comprised of 
randomly assigned subtests, their use appears questionable in determining validity. 
Certainly it would appear that there is little value in correlating cognitive assessment 
test accuracy to a randomly constructed neuropsychological battery. This concern is 
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compounded when extracting sections of other psychometric tests for use within the NP 
battery administered. NP battery may be useful in verifying the discriminant validity in 
relation to specific domains. However, overall, the manner in which neuropsychological 
battery has been utilised within the studies reviewed here has served to further 
complicate an already complex process. 
Clinician experience of functionality 
MoCA takes almost twice as long to administer, 5 to 30 minutes compared to 4 to 12 
minutes for MMSE’s. It is also a tool which clinicians are not as familiar with. Despite 
this clinicians found MoCA preferable to the MMSE (Aggarwal & Kean, 2010). MoCA 
facilitated discussion with other clinicians, it provided more information than MMSE 
and the findings were easy to interpret (Aggarwal & Kean, 2010).  
Ceiling effect 
Ceiling effect is said to occur when performance of a task is too easy and the resultant 
scoring is high. MMSE was found more prone to ceiling effect than MoCA (Roalf et al, 
2013; Pendlebury et al, 2012; Toglia et al, 2011; Pendlebury et al, 2010; Zadikoff, 
2008). Pendlebury et al (2012) found MMSE displayed ceiling effect in the domains of 
naming, registration, reading and writing where scoring almost reached the maximum. 
The screening test was prone to ceiling effect with selected populations, such as 
individuals with stroke when using MMSE (Toglia et al, 2011). The MMSE 
demonstrated a pronounced ceiling effect associated with the detection of cognitive 
impairment in individuals with Parkinson’s disease (PD) (Zadikoff et al., 2008). 
Similarly, a marked ceiling effect was found in the MMSE for younger, well-educated 
individuals (Roalf et al, 2013). MoCA was not without ceiling effect. Ceiling effect was 
said to have occurred in the animal naming task of MoCA (Damian, 2011), with the 
authors concluding that the task was too easy. Cumming et al (2012) reminded 
clinicians that data which is skewed toward ceiling does not necessarily imply that the 
tool has less sensitivity than another. 
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Cut off score 
Crawford, Whitnall, Robertson and Evans (2012) argue that cognitive screening tools 
offer an opportunity to detect the presence of cognitive impairment, although the results 
cannot be used to make a diagnosis of dementia. Screening tools can be judged by their 
ability to accurately distinguish between those individuals who have an element of 
cognitive impairment from those individuals who do not, and the distinguishing factor is 
based on ‘cut off’ scores. The validity of an instrument is evident in its sensitivity to 
detect cognitive impairment in an individual. Sensitivity denotes the probability that a 
cognitive assessment tool will correctly identify individuals who are cognitively 
impaired, whereas specificity is the ability of a cognitive assessment tool to 
categorically exclude a particular attribute in an individual (Wood, Guiliano, Bignell & 
Pritham, 2006). Both sensitivity and specificity are determined through the use of cut 
off scores which identify the score at or below which impairment is detected (Wood et 
al, 2006). However, cut off scores are neither consistently applied nor reported similarly 
which creates challenges when analysing data. Additionally, altering the cut off scores 
changes both sensitivity and specificity, potentially altering outcomes, which hampers 
the capacity to compare one study with another (Cumming et al., 2012; Damian et al., 
2011; Dong et al., 2012; Godefroy et al., 2011; Hoops et al., 2009).  
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Table 4: Sensitivity and specificity values 
This table demonstrates Mini Mental State Examination (MMSE) and Montreal 
Cognitive Assessment (MoCA) Sensitivity and Specificity totals for individual studies 
at cut off scores as specified. Highlighted figures indicate the highest result for that 
particular data set as given within each individual study. 
Key: - indicates no data available 
 
 
 
In evaluating the articles a decision was made to extrapolate available data relating to 
sensitivity and specificity in order to graph it. This allowed for trends to become 
apparent and Table 4 confirms that MoCA sensitivity is greater than that found for 
MMSE within each study. The converse is also apparent; MMSE specificity is greater 
than that found for MoCA. It can also be seen that there is little alignment between the 
values for either sensitivity or specificity across the studies. I suspect that this is 
secondary to the use of different statistical procedures applied in quantifying the level 
of impairment. Larner (2013) writes that “highly sensitive tests, which are generally 
thought desirable for screening purposes, will ensure that early cases are not missed 
but at the risk of making false positive diagnoses” (p.4). It is clearly demonstrated that 
MoCA is highly sensitive and therefore more likely than MMSE to identify early cases 
of cognitive impairment. However, secondary to the lower specificity of MoCA it is 
more likely to result in false positive diagnoses. In my opinion this finding is positive 
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as the aim is to utilise an instrument solely for screening purposes within the 
residential care setting; the results will be considered indicative and support the 
request that further investigation be conducted. 
Roalf et al (2013) identified that a statistical tool known as the Youden index can be 
used to determine the cut off score at which optimal differentiation occurs between 
groups and stated it maximised the trade-off between the two indicators, sensitivity 
and specificity. Youden index was used within several studies (Damian et al., 2011; 
Dong et al., 2012; Godefroy et al., 2011; Roalf et al., 2013; Tu et al., 2013). Damian et 
al (2011) cautions that the predictive value of the MoCA versus the MMSE changes 
with the prevalence of cognitive impairment in the population studied and this can be 
manipulated through changing the cut off score. Zadikoff et al (2008) acknowledged 
the need to consider a different cut off score in their study. Although they used the cut 
off score of < 26 for MCI, its appropriateness for accurately identifying MCI in PD 
populations has not been established.  
Statistics are becoming increasingly commonplace in the determination of cut off 
scores and an example includes the use of a statistical application known as receiver 
operating characteristic (ROC) analysis. This technique was used by Damian et al 
(2011) to demonstrate that use of varying cut off scores alters the predictive value of 
results, improving sensitivity at the expense of specificity. Damian et al (2011) 
indicated their finding allowed them to state that MoCA is more appropriate for 
screening purposes within settings such as primary care and a cut off score of < 24 
would result in superior predictive value in a memory clinic setting where there likely 
exists high prevalence for MCI. Cronbach alpha is another statistical tool used to 
determine the reliability of findings, with a result of .70 or less indicating an 
unacceptable level of reliability. In one study, Cronbach alpha result was .60 for 
MMSE which indicated that MMSE may not be reliable when subjects score at the 
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upper end of the continuum (Toglia et al, 2011). This finding is consistent with those 
of other studies (Godefroy et al, 2011; Aggarwal et al, 2010; Hoops et al, 2009). 
Cut off scores appear to be influenced by education. One study found that while 
“MoCA includes a minor correction for lower education levels, MMSE does not and 
this may affect the diagnostic accuracy of MMSE” (Hoops et al., 2009, p. 1743). 
Similarly, when controlling for the confounding effect of age and level of education in 
a post-stroke inpatient population, the use of new cut off scores resulted in improved 
sensitivity to the detriment of specificity when using MMSE and improved specificity 
to the detriment of sensitivity when using MoCA (Godefroy et al., 2011). The 
relationship between cut off scores and education was not directly mentioned in other 
studies: rather it was stated that additional points should be added to total scores where 
education levels are low, although the data varied with regard to application. I close 
this statistical summary which noted that “meta-analytic studies of quantitative 
accuracy are still in their infancy” (Larner, 2013, p. 230). 
Study populations 
Common comorbidities were included in the literature review as they frequently exist 
alongside cognitive impairment. In a population of sub-acute post-stroke patients the 
tasks of visuoexecutive function, delayed recall and verbal fluency were found to be 
those most impaired using MoCA (Toglia et al, 2011). Toglia et al identified that 
delayed recall was the lowest scoring task using MMSE, however, when analysing the 
mean percentage score for delayed recall in MoCA compared to the mean percentage 
score for delayed recall scoring in MMSE it can be seen that MoCA is more likely to 
classify impairments. One study identified that the “presence of cognitive impairment 
was associated with age, more severe neurological deficit, higher depression score, left 
sided stroke and poor outcome” (Godefroy et al, 2010; p. 1714). Conversely, Toglia et 
al found “no significant differences in MoCA visuospatial/executive subsection or 
total scores with side of the lesion” (p. 796). 
51 
 
Parkinson Disease 
Poor task performance has been noted in individuals with white matter 
hypersensitivities and those with Parkinson disease, although they are of different 
neuropathology, both have disrupted subcortical-frontal pathways (Julayanont et al., 
2013). Individuals with PD score poorly in the cognitive domains of attention, 
visuospatial and executive functioning, naming and repetition; this is consistent with 
error common to PD (Zadikoff et al., 2008). In examining MoCA sub-scores, Hoops et 
al (2009) report individuals with Parkinson disease and MCI or dementia were found 
to have deficits in the domains of attention, language, delayed recall, visuospatial and 
executive function and orientation. 
Establishing the presence of MCI 
Dong et al (2012) tried to establish the discriminant validity of the MoCA in detecting 
multi domain MCI (md-MCI) as this is the most common cognitive phenotype 
immediately prior to dementia conversion in PD. 75% of patients with md-MCI were 
impaired in at least four domains. The most impaired domains were visual memory 
and verbal memory as well as visuospatial/executive function, language and attention 
In their 2012 study Dong et al confirmed previous assumptions that MoCA was more 
suitable than the MMSE because of its capacity to screen for deficits in these cognitive 
domains. It has “more visuospatial and executive function sub tests as well as more 
demanding recall items” (p. 1753).  
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Chapter 6: Conclusion 
This project has been challenging secondary to rapidly evolving complexities within 
the field of assessment of cognitive impairment, as previously discussed. However, it 
has been possible to gain resolution to the research question. Through my involvement 
in working within residential care I was concerned that nurses lacked the availability 
of a brief cognitive assessment screening tool which was validated in the detection of 
cognitive impairment. There was inconsistency in the cognitive assessment tool of 
choice with many using MMSE and others using MoCA, which complicated 
transferral of information. 
I therefore embarked on a literature review in order to determine whether MoCA was a 
suitable replacement for MMSE. There is a plethora of literature written about all 
aspects of cognitive impairment and the main driver appears to be a search for the 
‘holy grail’; an assessment instrument which is capable of reliably translating physical 
and psychological symptomatology onto a scale to validate cognitive status. The 
MMSE, which has been the most commonly deployed instrument, must now be 
purchased for use and is free for use only when administered from memory. This may 
underpin the recent proliferation in cognitive assessment instruments. While the 
validity of the copyright issue is debatable, it nevertheless provides a deterrent to its 
use and has also underpinned a proliferation of more recent alternative screening 
instruments. A senior occupational therapist working within the local DHB confirmed 
that the DHB had moved to using MoCA as the preferred brief cognitive assessment 
tool subsequent to the copyright implications in using MMSE (Thompson, M; personal 
communication 10/12/2014). Enlarging on this statement he added that cognitive 
assessment was most appropriate where poor performance impacted on the functional 
capacity of an individual; MoCA permitted more information to be obtained in relation 
to executive function than was revealed using MMSE and this factor also contributed 
to a preference for MoCA. He closed in commenting that the MoCA was both easily 
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and rapidly administered, cautioning that it was a screen and therefore only an 
‘indication’ of cognitive difficulty. Further examination would be necessary to 
determine dementia or quantify cognitive status. 
Current research appears to have changed focus and now seeks to examine the utility 
of a cognitive assessment tool in relation to conditions such as Parkinson’s, stroke and 
congestive heart failure as opposed to its earlier focus in relation to Alzheimer’s 
disease dementia and dementia of other causes. This trend is accompanied by an 
imperative for an early diagnosis of cognitive impairment which aims to alleviate 
symptomatology, optimise the treatment of underlying and coexisting conditions and 
in some cases to prevent the progression of MCI to dementia. Understanding cognitive 
decline in relation to conditions which lead to dementia may assist in precipitating 
early detection as well as afford opportunity to optimise treatment for underlying 
conditions and comorbidity. 
Challenges were presented in analysis of the data because of the manner in which it is 
both applied and interpreted which leads to varied and questionable outcomes. The 
direction of future research, such as that being undertaken at present by Davis et al 
(2013) who aim to review the accuracy of several of the neuropsychological tests on 
behalf of the Cochrane diagnostic test accuracy reviews in dementia, will hopefully 
serve to provide much needed answers to an ever increasing number of questions. 
The limitations identified with this project research design include the vast amount of 
research available, making it difficult for one individual to digest alone within the 
constraints of time apportioned to a dissertation. Therefore, pertinent articles may not 
have been included as a result of oversight. In limiting the literature reviewed to 
articles written in English, bias is introduced through the exclusion of relevant studies 
which may have added value, offered alternative data or reached different conclusions. 
Statistical data within articles has the potential to be misinterpreted, however 
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conclusions have largely been drawn from the overall descriptions of findings within 
each of the studies. Potentially incorrect statistical data interpretation would not 
change the finding that MoCA is not only a suitable replacement for MMSE but 
affords early identification of cognitive impairment because it exhibits superior 
sensitivity to that of MMSE. 
The most consistent finding was that MoCA is found to be a more reliable cognitive 
assessment tool in the detection of cognitive impairment and superior to MMSE in the 
detection of mild cognitive impairment. Therefore, I do not hesitate to suggest that 
residential care in New Zealand adopt MoCA as the brief cognitive assessment 
screening tool of choice. This review has shown it to be of value in that it is a brief 
cognitive screener taking around 10 minutes to administer (Hoops et al., 2009; 
Narzarko, 2013; Nasreddine et al., 2005). It is convenient and accessible, available 
from the developer’s website www.mocatest.org where it is able to be downloaded and 
printed ready for use by the assessor at no cost. It is reliable and has been validated in 
detecting cognitive impairment and in particular is superior in detecting MCI 
compared to MMSE. Therefore the results, when positive, can be used to generate 
further review of an individual for whom there is concern. This finding reinforces the 
statement made by Nasreddine et al (2005) that “use of MoCA should provide quick 
guidance for referral and further investigation of MCI” (page 698). 
I would also recommend that routine cognitive screening of individuals at risk be 
considered. Such a programme would target individuals at high risk such as those who 
have a history of drug or alcohol dependence, history of a significant head injury, 
delirium, late onset anxiety or depression. Individuals reporting memory complaints 
should be considered for routine and interval screening to monitor for early cognitive 
disorder. Routine screening should be considered on admission to primary or 
secondary healthcare environments; in this way, a baseline quantification of cognition 
is ensured and decline can then be captured, measured and responded to proactively. 
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Routine screening would also align practice with the New Zealand Framework for 
Dementia Care (MOH, 2013). 
Nurses are able to be skilled in administering the MoCA with “very little training” 
(Roalf et al., 2013, p. 530). Training for nurses would align with the New Zealand 
Framework for Dementia Care through ensuring “health practitioners have skills and 
knowledge in cognitive assessment and knowledge of dementia” (MOH, 2013, p.16). 
Nursing has continuity in service across 24 hours and 7 days per week, whether they 
are situated directly on site or available on call, and have an established rapport with 
individuals and their families. Therefore nursing is well placed to use skill, knowledge 
and critical observation in combination with MoCA to ensure strong advocacy for 
those who do not themselves, have a voice. 
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Appendix A: CASP Tool Case Control Studies 
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Appendix B: Mini Mental State Examination (MMSE)  
Folstein, M., Folstein, S., & McHugh, P. (1975) 
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Appendix C: Montreal Cognitive Assessment (MoCA)  
Nasreddine et al. (2005)           
  
